Peptide Antibiotics Global Market Report 2025

Description

Peptide antibiotics are a type of antibiotics composed of peptides, and their antibacterial activity is based on the physical rupture of cell membranes. These antibiotics are designed to permeate bacterial membranes, accumulate within bacteria, and subsequently interfere with bacterial functioning.

The main types of peptide antibiotics include ribosomally synthesized peptide antibiotics and non-ribosomally synthesized peptide antibiotics. Ribosomally synthesized peptide antibiotics can either destroy or modify the drug, change the drug target, decrease or raise drug uptake, or substitute a different metabolic step as the medication's target. These antibiotics are antimicrobial peptides generated by ribosomes and produced by a wide range of species, from bacteria to plants and animals. Some examples of drugs under the category of peptide antibiotics include daptomycin, dalbavancin, telavancin, and other drugs used to treat various diseases such as skin infections, hospital-acquired bacterial pneumonia (HABP)/ventilator-associated bacterial pneumonia (VABP), bloodstream infections, and other conditions. Peptide antibiotics are utilized and distributed through channels like hospitals, homecare, specialty clinics, and other distribution channels.

The peptide antibiotics market research report is one of a series of new reports from The Business Research Company that provides peptide antibiotics market statistics, including peptide antibiotics industry global market size, regional shares, competitors with a peptide antibiotics market share, detailed peptide antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the peptide antibiotics industry. This peptide antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptide antibiotics market size has grown rapidly in recent years. It will grow from $5.25 billion in 2024 to $5.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to discovery and development of peptide antibiotics, increased antibiotic resistance, rise inThe incidence of infectious diseases, advances in peptide synthesis technologies, growth of The pharmaceutical industry.

The peptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $8.47 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emphasis on novel antibiotics development, increasing global incidence of antibiotic-resistant infections, expansion of research and development in antimicrobial peptides, regulatory support for new antibiotic approvals. Major trends in the forecast period include exploration of natural sources for antimicrobial peptides, application of peptide antibiotics in animal health, focus on peptide engineering for enhanced efficacy, development of combination peptide antibiotics, integration of ai and machine learning in peptide antibiotic discovery.

The rising prevalence of various infectious diseases is anticipated to drive the growth of the peptide antibiotics market. Infectious diseases are caused by harmful microorganisms, including bacteria, fungi, and parasites. Key factors contributing to the increase in infectious diseases include rapid urbanization, climate change, and a heightened risk of disease emergence, all of which have led to a greater demand for peptide antibiotics. Peptide antibiotics work by physically disrupting cell membranes, which underpins their antibacterial activity. For example, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that dengue cases in the Americas had already exceeded seven million by April 2024, significantly surpassing the 4.6 million cases recorded for the entire year of 2023. Therefore, the rising incidence of infectious diseases is fueling the growth of the peptide antibiotics market.

An increase in the prevalence of chronic diseases is expected to propel the growth of the peptide antibiotics market. Chronic diseases are defined as illnesses lasting a year or longer that require ongoing medical attention and restrict daily activities. The rise in chronic diseases can be attributed to factors such as increased tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption. Peptide antibiotics are utilized to treat chronic diseases by delivering the drug directly to the target area. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, reflecting a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic conditions is driving the expansion of the peptide antibiotics market.

A prominent trend in the peptide antibiotics market is the increasing adoption of strategic partnerships among major companies. This collaborative approach allows companies to expand their market reach and leverage each other's resources effectively. For instance, Berkeley Lights, a US-based digital cell biology company, forged a strategic partnership with Aanika Biosciences in January 2022. Through this collaboration, Aanika Biosciences aims to utilize Berkeley Lights' high-throughput, functional screening service to rapidly identify and refine functional antimicrobial peptides (AMPs) targeting harmful bacteria, particularly those responsible for foodborne disease outbreaks. The partnership also involves the utilization of the Beacon Optofluidic Platform to identify peptides harmful to bacteria, leading to the development of a novel antibacterial tag. This tag will be integrated into Aanika Biosciences' bacterial spore-based barcoding technology to enhance food supply chain security.

Major players in the peptide antibiotics market are also making strategic moves by introducing generic versions, providing a cost-effective alternative for patients. Generic versions, which are off-patent alternatives to brand-name peptide-based antibiotics, offer affordability without compromising efficacy. In July 2023, Camber Pharmaceuticals, a US-based pharmaceutical company, expanded its portfolio by launching a generic version of Daptomycin for Injection. This peptide antibiotic is a cyclic lipopeptide synthesized by nonribosomal machinery and is prescribed for treating complicated skin and skin structure infections (cSSSI) in both adult and pediatric patients aged 1 to 17 years.

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The peptide antibiotics market consists of sales of oral, intravenous, intramuscular and topical peptide antibiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptide Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptide antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptide antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Ribosomal Synthesized Peptide Antibiotics; Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin; Dalbavancin; Telavancin; Other Drugs
3) By Disease Outlook: Skin Infection; HABP Or VABP; Blood Stream Infection; Other Diseases
4) By Distribution Channel: Hospitals; Homecare; Specialty Clinics; Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides; Macrolides; Tetracyclines; Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins; Vancomycin; Polymyxins; Cyclic Lipopeptides
Companies Mentioned: Eli Lilly and Company; GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r21916

1. Executive Summary

2. Peptide Antibiotics Market Characteristics

3. Peptide Antibiotics Market Trends And Strategies

4. Peptide Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Peptide Antibiotics Growth Analysis And Strategic Analysis Framework

5.1. Global Peptide Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Peptide Antibiotics Market Growth Rate Analysis
5.4. Global Peptide Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Peptide Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Peptide Antibiotics Total Addressable Market (TAM)

6. Peptide Antibiotics Market Segmentation

6.1. Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ribosomal Synthesized Peptide Antibiotics
Non-rRibosomal Synthesized Peptide Antibiotics
6.2. Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Daptomycin
Dalbavancin
Telavancin
Other Drugs
6.3. Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Infection
HABP/VABP
Blood Stream Infection
Other Diseases
6.4. Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other Distribution Channels
6.5. Global Peptide Antibiotics Market, Sub-Segmentation Of Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aminoglycosides
Macrolides
Tetracyclines
Lincosamides
6.6. Global Peptide Antibiotics Market, Sub-Segmentation Of Non-Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacitracins
Vancomycin
Polymyxins
Cyclic Lipopeptides

7. Peptide Antibiotics Market Regional And Country Analysis

7.1. Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peptide Antibiotics Market

8.1. Asia-Pacific Peptide Antibiotics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peptide Antibiotics Market

9.1. China Peptide Antibiotics Market Overview
9.2. China Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peptide Antibiotics Market

10.1. India Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peptide Antibiotics Market

11.1. Japan Peptide Antibiotics Market Overview
11.2. Japan Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peptide Antibiotics Market

12.1. Australia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peptide Antibiotics Market

13.1. Indonesia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peptide Antibiotics Market

14.1. South Korea Peptide Antibiotics Market Overview
14.2. South Korea Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peptide Antibiotics Market

15.1. Western Europe Peptide Antibiotics Market Overview
15.2. Western Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peptide Antibiotics Market

16.1. UK Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peptide Antibiotics Market

17.1. Germany Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peptide Antibiotics Market

18.1. France Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peptide Antibiotics Market

19.1. Italy Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peptide Antibiotics Market

20.1. Spain Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peptide Antibiotics Market

21.1. Eastern Europe Peptide Antibiotics Market Overview
21.2. Eastern Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peptide Antibiotics Market

22.1. Russia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peptide Antibiotics Market

23.1. North America Peptide Antibiotics Market Overview
23.2. North America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peptide Antibiotics Market

24.1. USA Peptide Antibiotics Market Overview
24.2. USA Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peptide Antibiotics Market

25.1. Canada Peptide Antibiotics Market Overview
25.2. Canada Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peptide Antibiotics Market

26.1. South America Peptide Antibiotics Market Overview
26.2. South America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peptide Antibiotics Market

27.1. Brazil Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peptide Antibiotics Market

28.1. Middle East Peptide Antibiotics Market Overview
28.2. Middle East Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peptide Antibiotics Market

29.1. Africa Peptide Antibiotics Market Overview
29.2. Africa Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peptide Antibiotics Market Competitive Landscape And Company Profiles

30.1. Peptide Antibiotics Market Competitive Landscape
30.2. Peptide Antibiotics Market Company Profiles
- 30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Peptide Antibiotics Market Other Major And Innovative Companies

31.1. AbbVie Inc.
31.2. Sandoz International GmbH
31.3. Xellia APS
31.4. Johnson & Johnson Inc.
31.5. AstraZeneca PLC
31.6. Bayer AG
31.7. Bristol-Myers Squibb Company
31.8. Lupin Pharmaceuticals Inc.
31.9. Sun Pharmaceutical Industries Ltd.
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Torrent Pharmaceuticals Ltd.
31.12. Wockhardt Ltd.
31.13. Zydus Lifesciences Limited
31.14. Alkem Laboratories Limited
31.15. Allecra Therapeutics GmbH

32. Global Peptide Antibiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peptide Antibiotics Market

34. Recent Developments In The Peptide Antibiotics Market

35. Peptide Antibiotics Market High Potential Countries, Segments and Strategies

35.1 Peptide Antibiotics Market In 2029 - Countries Offering Most New Opportunities
35.2 Peptide Antibiotics Market In 2029 - Segments Offering Most New Opportunities
35.3 Peptide Antibiotics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer